Skip to main content

Market Overview

Benzinga's Weekend M&A Chatter

Share:

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday February 12 through Monday February 15, 2016:

Nasdaq Acquires Marketwired

The Deal:
Nasdaq, Inc. (NASDAQ: NDAQ) announced Friday, that it has agreed to acquire news distribution service provider Marketwired. Terms were not disclosed.

The deal is expected to close in Q1 of 2016.

Nasdaq closed at $61.31 on Friday, up 2.23%.

Intercept Pharmaceuticals Said to be Exploring Potential Sale

The Rumor:
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is said to be exploring a potential sale, according to sources reported by Reuters on Friday. The biotech company is working with investment bankers to assist in the review process, the sources said.

Intercept declined comment on the report.

Intercept Pharmaceuticals closed at $120.22 on Friday, up 27.50%.

Alon Blue Square Receives Updated Offers for Acquisition of Control of Company

The Offers:
Alon Blue Square Israel Ltd. (NYSE: BSI) announced Friday, it has been notified of the receipt of updated offers from Moti Ben-Moshe and Gindi Israel 2010 Ltd. for the acquisition of control of the company. Both offers provide for the acquisition of approximately 72.71% direct and indirect interest in the company held by Alon Israel Oil Company Ltd. for NIS 115 million, plus receipt of all rights derived from an approximately NIS 110 million loan that Alon Oil granted to the company.

The offers are subject to apprival by Alon and the company's creditors.

Alon Blue Square closed at $3.52 on Friday, up 6.67%.

 

Related Articles (BSI + ICPT)

View Comments and Join the Discussion!

Posted-In: M&A News Rumors Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com